Skip to main content

Find Clinical Trials

Home
Conditions
HR+HER2- Breast Cancer

Clinical trial condition

HR+HER2- Breast Cancer

Explore clinical trials studying HR+HER2- Breast Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

HR+HER2- Breast Cancer trial results

Not Yet Recruiting

Neoadjuvant Chemotherapy + PD-1 Inhibitor+Different Radiotherapy Fractionations for HR+/HER2- Breast Cancer

NCT06639672

Conditions: HR+HER2- Breast Cancer
Locations: Not specified

View Trial Details

Not Yet Recruiting

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer

NCT06404463

Conditions: Breast Diseases, Breast Neoplasms, Early Breast Cancer, +6 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer(PANKU-Breast01)

NCT06343948

Conditions: HR+HER2- Breast Cancer
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details